Wellness Bio Radar
Neuroscience-backed approaches to mental performance, stress resilience and cognitive optimisation.
232 articles
A new treatment combination is offering hope to cancer patients, particularly those in areas with limited healthcare resources. Researchers presented findings at the American Society of Clinical…
Highly sensitized patients received successful kidney transplants after undergoing CAR T-cell therapy at an unspecified US medical center in a recent study. The patients had previously been deemed…
Researchers at Johns Hopkins Medicine have successfully used a novel magnetic imaging technique to monitor cell therapy injections in mice. The study, conducted in June 2026, focused on treatments…
Newborn meningitis is a rare but life-threatening infection that affects premature babies more frequently. In Switzerland, researchers are working on a new therapy. One in five premature babies is…
A new analysis presented at the American Society of Clinical Oncology meeting in Chicago shows that patients with colorectal cancer who forego maintenance therapy after achieving a complete response…
Researchers at the University of California - San Diego made a breakthrough on June 1, 2026, in understanding cancer immunotherapy resistance. Immune checkpoint therapy is a type of cancer treatment…
Researchers at the University of Oulu conducted a study on the impact of physical activity on mental health in middle age. The study, published on June 1, 2026, analyzed the effects of different…
Years of effort to eliminate stigma in medicine are being undone. Robert F. Kennedy Jr.'s anti-vaccine movement is reviving a culture of blame. For decades, the medical community has worked to reduce…
The American Society of Clinical Oncology (ASCO) annual meeting will hear positive results from the RASolute 302 trial on June 1. Dana-Farber Cancer Institute's Brian Wolpin will present findings…
Jenna Carberg gave birth to her daughter Elsie in 2017. Moments after delivery, doctors placed the baby on her chest in Winter Park, Florida. This intimate moment is a common experience for new…
A multinational phase 3 study presented on May 29, 2026, shows that patients with relapsed multiple myeloma receiving the bispecific antibody teclistamab lived markedly longer than those on standard…
At the ASCO conference in Chicago, researchers presented findings on teclistamab, a bispecific antibody treatment for relapsed or refractory multiple myeloma. The study focused on patients who had…